These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35954390)

  • 1. A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma.
    Jiang Z; Luo Y; Zhang L; Li H; Pan C; Yang H; Cheng T; Chen J
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
    Zhou T; Yang P; Tang S; Zhu Z; Li X; Yang Z; Wu R; Tian X; Li L
    J Oncol; 2021; 2021():5512325. PubMed ID: 34367284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor microbiome derived glycolysis-lactate signatures depicts immune heterogeneity in lung adenocarcinoma by integration of microbiomic, transcriptomic, proteomic and single-cell data.
    Deng X; Chen X; Luo Y; Que J; Chen L
    Front Microbiol; 2023; 14():1202454. PubMed ID: 37664112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma.
    Shang S; Wang MZ; Xing Z; He N; Li S
    Front Immunol; 2022; 13():1024925. PubMed ID: 36505423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III-IV Lung Adenocarcinoma.
    Zhao H; Zhang X; Guo L; Shi S; Lu C
    Front Genet; 2021; 12():684281. PubMed ID: 34552612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analyses of one-carbon metabolism related genes and their association with prognosis, tumor microenvironment, chemotherapy resistance and immunotherapy in lung adenocarcinoma.
    Zhou N; Tang Q; Yu H; Li T; Ren F; Zu L; Chen G; Chen J; Xu S
    Front Mol Biosci; 2022; 9():1034208. PubMed ID: 36438661
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
    Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
    Front Immunol; 2022; 13():783495. PubMed ID: 35222371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma.
    Mu T; Li H; Li X
    Front Oncol; 2022; 12():867470. PubMed ID: 35494074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and Identification of Four Prognostic Genes Related to Immune Infiltration and G-Protein Coupled Receptors Pathway in Lung Adenocarcinoma.
    Wang Y; Qiu L; Chen Y; Zhang X; Yang P; Xu F
    Front Oncol; 2020; 10():622251. PubMed ID: 33628734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma.
    Zou Z; Chai Y; Li Q; Lin X; He Q; Xiong Q
    Front Oncol; 2022; 12():958221. PubMed ID: 36185199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma.
    Yu Z; Qiu B; Zhou H; Li L; Niu T
    Cancer Cell Int; 2023 Aug; 23(1):169. PubMed ID: 37580667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment.
    Huang D; Tang E; Zhang T; Xu G
    Front Immunol; 2022; 13():916284. PubMed ID: 35860256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.